SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-12-000973
Filing Date
2012-07-02
Accepted
2012-07-02 17:10:45
Documents
16
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K vsta10kmar312012.htm 10-K 4088539
2 ARTICLES OF MERGER ex3-2.htm EX-3.2 88567
3 CERTIFICATE OF AMENDMENT ex3-3.htm EX-3.3 11926
4 UHN LICENSE AGREEMENT ex10-57.htm EX-10.57 150290
5 EXCHANGE AGREEMENT ex10-58.htm EX-10.58 74749
6 SECURED PROMISSORY NOTE ex10-59.htm EX-10.59 59599
7 SECURITY AGREEMENT ex10-60.htm EX-10.60 93182
8 EXHIBIT 31.1 ex31-1.htm EX-31.1 9175
9 EXHIBIT 31.2 ex31-2.htm EX-31.2 9340
10 EXHIBIT 32 ex32.htm EX-32 4837
  Complete submission text file 0001415889-12-000973.txt   9081645

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY INSTANCE DOCUMENT vsta-20120331.xml EX-101.INS 1029593
12 XBRL TAXONOMY SCHEMA DOCUMENT vsta-20120331.xsd EX-101.SCH 60063
13 XBRL TAXONOMY CALCULATION LINKBASE DOCUMENT vsta-20120331_cal.xml EX-101.CAL 51368
14 XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT vsta-20120331_def.xml EX-101.DEF 67368
15 XBRL TAXONOMY LABEL LINKBASE DOCUMENT vsta-20120331_lab.xml EX-101.LAB 313613
16 XBRL TAXONOMY PRESENTATION LINKBASE DOCUMENT vsta-20120331_pre.xml EX-101.PRE 157640
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-54014 | Film No.: 12941167
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences